(S (S (VP (ADVP (RB Accurately)) (VBG predicting) (NP (NP (NN drug) (NNS responses)) (PP (TO to) (NP (NN cancer)))))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN problem)) (VP (VBG hindering) (NP (NP (NNS oncologists) (POS â€º)) (NNS efforts) (S (VP (S (VP (TO to) (VP (VB find) (NP (NP (DT the) (ADJP (RBS most) (JJ effective)) (NNS drugs)) (SBAR (S (VP (TO to) (VP (VB treat) (NP (NN cancer)))))))))) (, ,))) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (NN core) (NN goal)) (PP (IN in) (NP (NN precision) (NN medicine))))))))))) (. .))
(S (NP (DT The) (JJ scientific) (NN community)) (VP (VBZ has) (VP (VBN focused) (PP (IN on) (S (VP (VBG improving) (NP (NP (DT this) (NN prediction)) (PP (VBN based) (PP (IN on) (NP (NP (ADJP (JJ genomic) (, ,) (JJ epigenomic) (, ,) (CC and) (JJ proteomic)) (NNS datasets)) (VP (VBN measured) (PP (IN in) (NP (JJ human) (NN cancer) (NN cell) (NNS lines))))))))))))) (. .))
(S (NP (NNP Real-world) (NN cancer) (NN cell) (NNS lines)) (VP (VBP contain) (NP (NP (NN noise)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ degrades) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NN machine) (VBG learning) (NNS algorithms))))))))) (. .))
(S (NP (DT This) (NN problem)) (VP (VBZ is) (VP (ADVP (RB rarely)) (VBN addressed) (PP (IN in) (NP (DT the) (VBG existing) (NNS approaches))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (NP (DT a) (JJ noise-filtering) (NN approach)) (SBAR (WHNP (WDT that)) (S (VP (VBZ integrates) (NP (NP (NNS techniques)) (PP (IN from) (NP (NP (JJ numerical) (JJ linear) (NN algebra)) (CC and) (NP (NN information) (NN retrieval)))) (VP (VBN targeted) (PP (IN at) (S (VP (VBG filtering) (PRT (RP out)) (NP (JJ noisy) (NN cancer) (NN cell) (NNS lines)))))))))))) (. .))
(S (PP (IN By) (S (VP (VBG filtering) (PRT (RP out)) (NP (JJ noisy) (NN cancer) (NN cell) (NNS lines))))) (, ,) (NP (PRP we)) (VP (MD can) (VP (VB train) (NP (NN machine) (VBG learning) (NN algorithms)) (PP (IN on) (NP (ADJP (JJR better) (NN quality)) (NN cancer) (NN cell) (NNS lines))))) (. .))
(S (NP (PRP We)) (VP (VP (VBP evaluate) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (PRP$ our) (NN approach))))) (CC and) (VP (VB compare) (NP (PRP it)) (PP (IN with) (NP (NP (DT an) (VBG existing) (NN approach)) (VP (VBG using) (NP (NP (NP (DT the) (NNP Area)) (PP (IN Under) (NP (DT the) (NNP ROC) (NNP Curve)))) (PRN (-LRB- -LRB-) (NP (NNP AUC)) (-RRB- -RRB-))) (PP (IN on) (NP (JJ clinical) (NN trial) (NNS data)))))))) (. .))
(S (NP (DT The) (JJ experimental) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (VBN proposed) (NN approach)) (VP (VP (VBZ is) (ADJP (JJ stable))) (CC and) (VP (ADVP (RB also)) (VBZ yields) (NP (DT the) (JJS highest) (NN AUC)) (PP (IN at) (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN level)))))))) (. .))
